We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Automated Workstation Screens Urine Before Culture

By LabMedica International staff writers
Posted on 20 Feb 2013
Automated systems have been developed to screen urine in order to eliminate those in which a culture is highly unlikely to yield clinically relevant results.

A flow cytometry system that quantifies urine elements associated with urinary tract infection (UTI) has recently added a new element, the detection of “all small particles” (ASP) to improve the sensitivity of the assay.

Scientists at the Veterans Affairs Medical Center (Houston, TX, USA) evaluated 1,000 urine specimens submitted consecutively that had a urine culture and urinalysis ordered on the same day. More...
Specimens were tested for leukocyte esterase and nitrite with a chemistry dipstick analyzer and for white blood cells (WBC), ASP, bacteria, and yeast with an automated urinalysis system. Urinary samples were also tested on bacterial culture plates.

There were 893 samples from male patients, and 107 from females. There were 123 specimens from patients with indwelling urinary catheters. Of the 1,000 specimens evaluated 604 (60.4%) were culture positive at any level, that is equal to or greater than 103 colony forming units (CFU)/mL. Two combinations of results available on the iQ200 Workstation (Iris Diagnostics; Chatsworth, CA, USA) were assessed for sensitivity, specificity, and negative predictive value (NPV).One method assessed leukocyte esterase, WBCs, nitrite, and the presence of few or more bacteria or yeast, a combination chosen to reflect the current parameters combination of manual urinalysis strips and standard microscopy. The other method assessed WBCs, the presence of few or more bacteria or yeast, and an ASP count of greater than 10,000, thus eliminating the redundancy of biochemical markers and focusing on the microscopic elements available on the iQ200.

The iQ200 Workstation is used in combination with the Aution Max AX-4280 chemistry dipstick analyzer (Arkray; Edina, MN, USA). The scientists found that the dipstick analysis added no advantage in a laboratory with microscopy. Although specificities were generally low, between 65.6% and 70.1%, the goal for screening samples is high sensitivity and NPV. The NPV approached 95% in comparison to the gold standard, but was further improved to greater than 99% when compared to the ordering clinician's diagnosis or an expert review that assessed the indications in the record that a UTI was present. The authors concluded that ASP did not enhance specificity, sensitivity, or NPV. The iQ200 Workstation performed well by any standard, thus providing a reliable system by which to improve the use of laboratory resources. The study was published in the January 2013 issue of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Veterans Affairs Medical Center
Iris Diagnostics
Arkray



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.